You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

cough hypersensitivity

Showing 1 - 25 of 4,381
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cough Trial in Missoula (Supra-threshold and progressive doses of diluted capsaicin via a dosimeter-controlled nebulizer,

Completed
  • Cough
  • Supra-threshold and progressive doses of diluted capsaicin via a dosimeter-controlled nebulizer
  • Saline
  • Missoula, Montana
    University of Montana
Nov 2, 2022

Cough Trial in Parkville (Adenosine Triphosphate, Capsaicin, Functional Brain Imaging)

Completed
  • Cough
  • Adenosine Triphosphate
  • +2 more
  • Parkville, Victoria, Australia
    The University of Melbourne
Jun 10, 2022

Cough, Upper Respiratory Tract Infections Trial in Carlton (Flurbiprofen Oral Lozenge, Difflam, Flurbiprofen 8.75 MG)

Recruiting
  • Cough
  • Upper Respiratory Tract Infections
  • Flurbiprofen Oral Lozenge
  • +2 more
  • Carlton, Victoria, Australia
    University of Melbourne
Jul 23, 2023

Impact of ATP on Laryngeal Symptoms, Hypersensitivity and

Recruiting
  • Chronic Refractory Cough
  • Laryngeal sensitivity testing
  • Copenhagen, Denmark
    Bispebjerg Hospital
Nov 28, 2022

Cough Trial in Missoula (Supra-threshold and progressive doses of diluted capsaicin via a Koko Digidoser nebulizer,

Completed
  • Cough
  • Supra-threshold and progressive doses of diluted capsaicin via a Koko Digidoser nebulizer
  • Sub-threshold doses of diluted capsiacin via a KoKo Digidoser nebulizer
  • Missoula, Montana
    University of Montana
Feb 25, 2021

Laryngeal Nerve Block, Chronic Neurogenic Cough, Laryngeal Hypersensitivity Trial in Norfolk (Steroid/Anesthesia Mixture,

Recruiting
  • Laryngeal Nerve Block
  • +2 more
  • Steroid/Anesthesia Mixture
  • Placebo
  • Norfolk, Virginia
    Eastern Virginia Medical School Ear, Nose, and Throat Surgeons
Mar 14, 2022

Pertussis Immunisation and Food Allergy

Completed
  • Food Allergy
    • Subiaco, Western Australia, Australia
      Princess Margaret Childrens Hospital
    Aug 6, 2020

    Allergic Rhinitis, Cough Trial (Bepotastine, Placebo)

    Completed
    • Allergic Rhinitis
    • Cough
    • Seoul, Korea, Republic of
      Asan medical center
    Jan 3, 2023

    Chronic Cough Trial in Parkville (Gefapixant)

    Not yet recruiting
    • Chronic Cough
    • Parkville, Victoria, Australia
      The University of Melbourne
    Apr 18, 2023

    Cough Trial (device, diagnostic test, procedure)

    Not yet recruiting
    • Cough
    • Adenosine triphosphate (ATP) solution inhalation from nebuliser
    • +7 more
    • (no location specified)
    Jan 26, 2023

    Chronic Refractory Cough (CRC) With Non-atopic Asthma, CRC With Atopic Asthma, Unexplained Chronic Cough Trial (drug, other,

    Not yet recruiting
    • Chronic Refractory Cough (CRC) With Non-atopic Asthma
    • +4 more
    • (no location specified)
    Jan 9, 2023

    Chronic Cough Trial in United States (ADX-629, Placebo)

    Recruiting
    • Chronic Cough
    • San Diego, California
    • +13 more
    Sep 21, 2022

    Refractory Chronic Cough Trial in Rochester (Duloxetine 30 MG, Duloxetine 60 MG, Amitriptyline 25 MG)

    Recruiting
    • Refractory Chronic Cough
    • Duloxetine 30 MG
    • +5 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Nov 4, 2022

    Drug Allergy Trial in Istanbul (diagnostics)

    Completed
    • Drug Allergy
    • diagnostics
    • Istanbul, Turkey
      Istanbul University-Cerrahpasa
    Jan 20, 2023

    Asthma, Cough Variant Asthma Trial in Kingston (high-dose methacholine challenge test, mannitol challenge test)

    Completed
    • Asthma
    • Cough Variant Asthma
    • high-dose methacholine challenge test
    • mannitol challenge test
    • Kingston, Ontario, Canada
      Kingston General Hospital
    Feb 9, 2022

    Peanut Allergy Trial in Canada, United States (AR101)

    Completed
    Has Results
    • Peanut Allergy
    • AR101
    • Birmingham, Alabama
    • +59 more
    Oct 5, 2021

    Cough Trial in Newcastle, Kuopio (Mannitol challenge)

    Recruiting
    • Cough
    • Mannitol challenge
    • Newcastle, New South Wales, Australia
    • +1 more
    Feb 28, 2022

    Anxiety and Reflux Symptoms in Gastroesophageal Reflux Disease

    Completed
    • GERD - Gastro-Esophageal Reflux Disease
    • Anxiety Disorders
    • High-Resolution Manometry, Upper-GI endoscopy, pH-Impedance testing
    • Cologne, NRW, Germany
      Department of General, Visceral, Tumor and Transplantation Surge
    Nov 28, 2023

    Called UV Population, to Learn More About Safety of Study Drug

    Recruiting
    • Contrast Enhanced X-ray Based Examination
    • Iopromide (Ultravist, BAY86-4877)
    • Multiple Locations, Germany
      Many Locations
    Jul 26, 2022

    Cough, ILD, Pulmonary Disease Trial in Hamilton, Toronto (Non-pharmacological Cough control Therapy)

    Recruiting
    • Cough
    • +3 more
    • Non-pharmacological Cough control Therapy
    • Toronto, Ontario, Canada
      Ana Oliveira
    Feb 19, 2021

    Peanut Allergy Trial in Worldwide (AR101)

    Enrolling by invitation
    • Peanut Allergy
    • AR101
    • Birmingham, Alabama
    • +91 more
    Feb 24, 2022

    Chronic Cough, Type 2 Diabetes Trial in Toulouse (Cough assessment, Neurological tests and cardiovascular tests, Skin biopsy)

    Unknown status
    • Chronic Cough
    • Type 2 Diabetes
    • Cough assessment
    • +2 more
    • Toulouse, France
      Hôpital Larrey
    Nov 9, 2020

    Cough, Asthma, COPD Trial (C-mo System)

    Not yet recruiting
    • Cough
    • +4 more
    • C-mo System
    • (no location specified)
    Aug 4, 2023

    Cough Trial in Chengdu (Zihua Wenfei Zhisou Granule, Placebo)

    Recruiting
    • Cough
    • Zihua Wenfei Zhisou Granule
    • Placebo
    • Chengdu, Sichuan, China
      West China Hospital of Sichuan University
    Mar 7, 2023

    Peanut Allergy Trial in Canada, United States (AR101, Placebo)

    Completed
    Has Results
    • Peanut Allergy
    • AR101
    • Placebo
    • Birmingham, Alabama
    • +66 more
    Oct 5, 2021